CAM
PFE icon

CMT Asset Management’s Pfizer PFE Stock Holding History

CMT Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-742,121
Closed -$25.1M – 103
2017
Q3 		$25.1M Sell
742,121
-118,786
-14% -$3.82M 1.21% 25
2017
Q2 		$27.4M Sell
860,907
-96,652
-10% -$3.05M 1.83% 12
2017
Q1 		$31.1M Sell
957,559
-664,125
-41% -$20.9M 2.62% 8
2016
Q4 		$50M Buy
1,621,684
+280,996
+21% +$8.58M 2.34% 9
2016
Q3 		$43.1M Buy
1,340,688
+141,763
+12% +$4.74M 1.98% 8
2016
Q2 		$40.1M Buy
1,198,925
+358,992
+43% +$11.5M 2.02% 10
2016
Q1 		$23.6M Sell
839,933
-532,797
-39% -$15.2M 1.58% 18
2015
Q4 		$42M Buy
1,372,730
+788,076
+135% +$24.8M 2.15% 12
2015
Q3 		$17.4M Buy
584,654
+37,839
+7% +$1.21M 0.98% 32
2015
Q2 		$17.4M Buy
546,815
+257,597
+89% +$8.4M 1.07% 31
2015
Q1 		$9.55M Sell
289,218
-175,807
-38% -$5.59M 0.69% 48
2014
Q4 		$13.7M Sell
465,025
-136,177
-23% -$3.9M 0.81% 37
2014
Q3 		$16.9M Sell
601,202
-88,009
-13% -$2.47M 0.87% 35
2014
Q2 		$19.4M Buy
+689,211
New +$19.6M 1.04% 28
2014
Q1 		– Sell
-348,979
Closed -$10.1M – 121
2013
Q4 		$10.1M Sell
348,979
-47,957
-12% -$1.4M 0.5% 62
2013
Q3 		$10.8M Sell
396,936
-114,254
-22% -$3.11M 0.55% 52
2013
Q2 		$13.6M Buy
+511,190
New +$14.1M 0.66% 48

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CMT Asset Management's PFE Position: Q2 2017 in Review

CMT Asset Management sold out of Pfizer (PFE) in Q2 2017, closing a stake of 38,418 shares — an estimated $1.21M sold.

CMT Asset Management first reported a position in PFE in Q4 2013 and held it in 8 quarters. The position peaked at $6.57M in Q3 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • CMT Asset Management reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • CMT Asset Management sold 38,418 Pfizer shares in Q2 2017, an estimated $1.21M.
  • CMT Asset Management first reported a position in Pfizer in Q4 2013 and held it in 8 quarters.
  • CMT Asset Management's Pfizer position peaked at $6.57M in Q3 2016.
  • 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on CMT Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.